In the last trading session, 0.19 million shares of the NeuroOne Medical Technologies Corp (NASDAQ:NMTC) were traded, and its beta was 0.64. Most recently the company’s share price was $1.05, and it changed around $0.01 or 0.95% from the last close, which brings the market valuation of the company to $32.40M. NMTC currently trades at a discount to its 52-week high of $1.59, offering almost -51.43% off that amount. The share price’s 52-week low was $0.55, which indicates that the current value has risen by an impressive 47.62% since then. We note from NeuroOne Medical Technologies Corp’s average daily trading volume that its 10-day average is 0.29 million shares, with the 3-month average coming to 193.71K.
NeuroOne Medical Technologies Corp stock received a consensus recommendation rating of Buy, based on a mean score of 3.00. If we narrow it down even further, the data shows that 0 out of 2 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended NMTC as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. NeuroOne Medical Technologies Corp is expected to report earnings per share of 0 for the current quarter.
NeuroOne Medical Technologies Corp (NASDAQ:NMTC) trade information
Instantly NMTC has showed a green trend with a performance of 0.95% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 1.2800 on recent trading dayincreased the stock’s daily price by 17.97%. The company’s shares are currently up 27.13% year-to-date, but still down -7.18% over the last five days. On the other hand, NeuroOne Medical Technologies Corp (NASDAQ:NMTC) is 38.80% up in the 30-day period. We can see from the shorts that 95520.0 shares have been sold at a short interest cover period of 0.6 day(s).
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 23.14%.
NMTC Dividends
NeuroOne Medical Technologies Corp’s next quarterly earnings report is expected to be released in February.
NeuroOne Medical Technologies Corp (NASDAQ:NMTC)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 16.02% of NeuroOne Medical Technologies Corp shares, and 19.43% of them are in the hands of institutional investors. The stock currently has a share float of 23.14%. NeuroOne Medical Technologies Corp stock is held by 23.0 institutions, with NANTAHALA CAPITAL MANAGEMENT, LLC being the largest institutional investor. By 2024-06-30, it held 3.6702% of the shares, which is about 0.95 million shares worth $0.76 million.
VANGUARD GROUP INC, with 3.5489% or 0.92 million shares worth $0.74 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund were the top two Mutual Funds as of Sep 30, 2024 . The former held 712.45 shares worth $0.75 million, making up 5.96% of all outstanding shares. On the other hand, Vanguard Extended Market Index Fund held roughly 207.08 shares worth around $0.22 million, which represents about 1.73% of the total shares outstanding.
